← Evidence map

ArticleThe lancet. Diabetes & endocrinology2015

Preventing cardiovascular events with empagliflozin: at what cost?

Huseyin Naci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 26590682